X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-27 | ROIV | Venker Eric | Pres, COO | S - Sale+OE | $13.02 | -500,000 | 595,397 | -46% | -$6,510,000 | |||||
| D | 2023-09-08 | ROIV | Venker Eric | COO | S - Sale+OE | $12.19 | -106,430 | 611,813 | -15% | -$1,297,382 | |||||
| D | 2023-09-08 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale+OE | $12.18 | -99,350 | 197,950 | -33% | -$1,210,083 | |||||
| D | 2023-09-05 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale+OE | $12.00 | -1,724 | 197,950 | -1% | -$20,688 | |||||
| DM | 2023-09-01 | ROIV | Venker Eric | COO | S - Sale+OE | $11.91 | -93,964 | 611,813 | -13% | -$1,119,341 | |||||
| D | 2023-08-14 | ROIV | Venker Eric | COO | S - Sale+OE | $11.89 | -59,811 | 627,918 | -9% | -$711,153 | |||||
| D | 2023-08-03 | ROIV | Venker Eric | COO | S - Sale+OE | $11.93 | -44,629 | 627,918 | -7% | -$532,424 | |||||
| DM | 2023-08-01 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale+OE | $12.00 | -4,017 | 199,328 | -2% | -$48,204 | |||||
| DM | 2023-07-31 | ROIV | Venker Eric | COO | S - Sale+OE | $11.91 | -195,166 | 627,918 | -24% | -$2,324,221 | |||||
| DM | 2023-07-25 | ROIV | Venker Eric | COO | S - Sale+OE | $10.91 | -125,534 | 627,918 | -17% | -$1,369,812 | |||||
| DM | 2023-07-20 | ROIV | Venker Eric | Pres, COO | S - Sale+OE | $11.19 | -374,466 | 627,918 | -37% | -$4,189,880 | |||||
| DM | 2023-07-14 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale+OE | $12.00 | -635 | 82,128 | -1% | -$7,620 | |||||
2023-06-22 | ROIV | Viking Global Investors LP | 10% | S - Sale | $9.90 | -13,000,000 | 12,884,307 | -50% | -$128,700,000 | ||||||
2023-06-22 | ROIV | Viking Global Performance LLC | 10% | S - Sale | $9.90 | -13,000,000 | 12,884,307 | -50% | -$128,700,000 | ||||||
2023-06-22 | ROIV | Sumitomo Chemical Co., Ltd. | 10% | S - Sale | $8.60 | -15,116,277 | 71,251,083 | -18% | -$129,999,982 | ||||||
| D | 2023-06-09 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale+OE | $9.93 | -43,893 | 198,582 | -18% | -$435,857 | |||||
| DM | 2023-06-07 | ROIV | Venker Eric | Pres, COO | S - Sale+OE | $9.91 | -299,585 | 660,097 | -31% | -$2,968,875 | |||||
| D | 2023-05-23 | ROIV | Venker Eric | Pres, COO | S - Sale+OE | $9.85 | -415 | 660,097 | 0% | -$4,088 | |||||
| D | 2023-05-09 | ROIV | Venker Eric | Pres, COO | S - Sale+OE | $9.23 | -238,724 | 675,768 | -26% | -$2,203,423 | |||||
| DM | 2023-05-04 | ROIV | Venker Eric | Pres, COO | S - Sale+OE | $8.56 | -150,044 | 675,768 | -18% | -$1,283,925 | |||||
| DM | 2023-05-01 | ROIV | Venker Eric | Pres, COO | S - Sale+OE | $8.40 | -288,989 | 675,768 | -30% | -$2,427,129 | |||||
| DM | 2023-05-01 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale+OE | $8.55 | -77,736 | 200,139 | -28% | -$664,492 | |||||
| DM | 2023-04-26 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale+OE | $8.56 | -230,788 | 200,139 | -54% | -$1,976,057 | |||||
| DM | 2023-04-26 | ROIV | Venker Eric | Pres, COO | S - Sale+OE | $8.55 | -222,243 | 675,768 | -25% | -$1,899,191 | |||||
2023-03-20 | ROIV | Svf Investments (Uk) Ltd | 10% | S - Sale | $8.00 | -12,000,000 | 83,031,667 | -13% | -$96,000,000 | ||||||
2023-03-01 | ROIV | Pulik Richard | CFO | S - Sale | $8.08 | -1,912 | 223,347 | -1% | -$15,449 | ||||||
2023-02-22 | ROIV | Ramaswamy Vivek | Dir | S - Sale | $7.95 | -4,000,000 | 54,409,211 | -7% | -$31,800,000 | ||||||
2023-01-05 | ROIV | Venker Eric | Pres, COO | S - Sale | $8.02 | -24,037 | 729,429 | -3% | -$192,777 | ||||||
| M | 2022-12-30 | ROIV | Venker Eric | Pres, COO | S - Sale | $7.46 | -119,245 | 753,466 | -14% | -$889,031 | |||||
| M | 2022-12-08 | ROIV | Venker Eric | Pres, COO | S - Sale | $7.03 | -145,105 | 888,742 | -14% | -$1,019,736 | |||||
2022-11-10 | ROIV | Svf Investments (Uk) Ltd | 10% | S - Sale | $4.75 | -4,343,919 | 95,031,667 | -4% | -$20,633,615 | ||||||
2022-11-10 | ROIV | Qvt Financial LP | Director by Deputization, 10% | S - Sale | $4.75 | -5,656,081 | 122,431,775 | -4% | -$26,866,385 | ||||||
2022-11-10 | ROIV | Gold Daniel Allen | Dir | S - Sale | $4.75 | -5,656,081 | 122,483,917 | -4% | -$26,866,385 | ||||||
2022-11-10 | ROIV | Manchester Keith S | Dir | S - Sale | $4.75 | -3,922,504 | 84,506,413 | -4% | -$18,631,894 | ||||||
2022-11-10 | ROIV | Dexcel Pharma Technologies Ltd. | 10% | P - Purchase | $5.00 | +4,000,000 | 102,849,443 | +4% | +$20,000,000 | ||||||
2022-10-25 | ROIV | Gline Matthew | CEO | S - Sale | $4.40 | -19,276 | 1,164,009 | -2% | -$84,814 | ||||||
2022-10-25 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale | $4.40 | -1,588 | 139,354 | -1% | -$6,987 | ||||||
2022-10-25 | ROIV | Venker Eric | Pres, COO | S - Sale | $4.40 | -15,922 | 1,049,850 | -1% | -$70,057 | ||||||
2022-09-23 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale | $3.07 | -1,741 | 140,942 | -1% | -$5,345 | ||||||
2022-09-23 | ROIV | Venker Eric | Pres, COO | S - Sale | $3.07 | -17,392 | 1,065,772 | -2% | -$53,393 | ||||||
2022-09-23 | ROIV | Gline Matthew | CEO | S - Sale | $3.07 | -21,053 | 1,183,285 | -2% | -$64,633 | ||||||
2022-08-24 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale | $3.71 | -1,652 | 142,683 | -1% | -$6,129 | ||||||
2022-08-24 | ROIV | Venker Eric | Pres, COO | S - Sale | $3.71 | -16,530 | 1,083,164 | -2% | -$61,326 | ||||||
2022-08-24 | ROIV | Gline Matthew | CEO | S - Sale | $3.71 | -20,009 | 1,204,338 | -2% | -$74,233 | ||||||
2022-07-25 | ROIV | Gline Matthew | CEO | S - Sale | $4.33 | -20,455 | 1,224,347 | -2% | -$88,570 | ||||||
2022-07-25 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale | $4.33 | -1,686 | 144,335 | -1% | -$7,300 | ||||||
2022-07-25 | ROIV | Venker Eric | Pres, COO | S - Sale | $4.33 | -16,896 | 1,099,694 | -2% | -$73,160 | ||||||
2022-06-23 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale | $4.34 | -1,635 | 146,021 | -1% | -$7,096 | ||||||
2022-06-23 | ROIV | Gline Matthew | CEO | S - Sale | $4.34 | -19,855 | 1,244,802 | -2% | -$86,171 | ||||||
2022-06-23 | ROIV | Venker Eric | Pres, COO | S - Sale | $4.34 | -16,402 | 1,116,590 | -1% | -$71,185 | ||||||
2022-05-20 | ROIV | Gline Matthew | CEO | S - Sale | $3.70 | -139,791 | 1,264,657 | -10% | -$517,227 | ||||||
2022-05-20 | ROIV | Venker Eric | Pres, COO | S - Sale | $3.70 | -136,421 | 1,132,992 | -11% | -$504,758 | ||||||
2022-05-20 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale | $3.70 | -12,127 | 147,656 | -8% | -$44,870 | ||||||
2022-04-25 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale | $3.84 | -703 | 159,783 | 0% | -$2,700 | ||||||
2022-04-25 | ROIV | Venker Eric | Pres, COO | S - Sale | $3.84 | -5,107 | 1,269,413 | 0% | -$19,611 | ||||||
2022-04-25 | ROIV | Gline Matthew | CEO | S - Sale | $3.84 | -8,509 | 1,404,448 | -1% | -$32,675 | ||||||
| M | 2022-04-22 | ROIV | Dexcel Pharma Technologies Ltd. | 10% | P - Purchase | $3.85 | +40,285 | 98,849,443 | 0% | +$154,954 | |||||
2022-03-30 | ROIV | Venker Eric | Pres, COO | S - Sale | $4.84 | -19,336 | 1,274,520 | -1% | -$93,586 | ||||||
2022-03-30 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale | $4.84 | -2,486 | 160,486 | -2% | -$12,032 | ||||||
2022-03-30 | ROIV | Gline Matthew | CEO | S - Sale | $4.84 | -33,686 | 1,412,957 | -2% | -$163,040 | ||||||
2022-03-25 | ROIV | Venker Eric | Pres, COO | S - Sale | $5.06 | -80,045 | 1,308,948 | -6% | -$405,028 | ||||||
2022-03-25 | ROIV | Gline Matthew | CEO | S - Sale | $5.06 | -35,386 | 1,471,897 | -2% | -$179,053 | ||||||
2022-03-25 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale | $5.06 | -7,281 | 165,049 | -4% | -$36,842 | ||||||
2022-03-18 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale | $5.13 | -2,153 | 172,330 | -1% | -$11,045 | ||||||
2022-03-18 | ROIV | Gline Matthew | CEO | S - Sale | $5.13 | -82,006 | 1,507,283 | -5% | -$420,691 | ||||||
2022-03-07 | ROIV | Kumar Rakhi | Chief Accounting Officer | S - Sale | $5.52 | -3,091 | 174,483 | -2% | -$17,062 | ||||||
2022-03-07 | ROIV | Gline Matthew | CEO | S - Sale | $5.52 | -92,324 | 1,589,289 | -5% | -$509,628 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |